Dietary capsaicin ameliorates pressure overload-induced cardiac hypertrophy and fibrosis through the transient receptor potential vanilloid type 1

American Journal of Hypertension

Volumn 27, Issue 12, 2014, Pages 1521-1529

  Wang, Qiang ^a   Ma, Shuangtao ^a   Li, De ^a   Zhang, Yan ^a   Tang, Bing ^a   Qiu, Chenming ^a   Yang, Yongjian ^a   Yang, Dachun ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

Blood pressure; Capsaicin; Cardiac fibrosis; Cardiac hypertrophy; Hypertension; Transient receptor potential vanilloid type 1

Indexed keywords

CAPSAICIN; COLLAGENASE 3; CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE A; GELATINASE B; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR; VANILLOID RECEPTOR SUBTYPE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA SURGERY; AORTIC BANDING; ARTICLE; CONTROLLED STUDY; HEART FIBROBLAST; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; CARDIOMEGALY; CARDIOMYOPATHIES; CELL PROLIFERATION; COMPLICATION; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; FLOW CYTOMETRY; HEART MUSCLE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CAPSAICIN; CARDIOMEGALY; CARDIOMYOPATHIES; CELL PROLIFERATION; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FIBROSIS; FLOW CYTOMETRY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; SIGNAL TRANSDUCTION; TRPV CATION CHANNELS;

EID: 84925684948     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpu068     Document Type: Article

References (30)

1. Roger VL. Epidemiology of heart failure. Circ Res 2013; 113:646-659.
2. Ho JE, Liu C, Lyass A, Courchesne P, Pencina MJ, Vasan RS, Larson MG, Levy D. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol 2012; 60:1249-1256.
3. Lijnen PJ, Maharani T, Finahari N, Prihadi JS. Serum collagen markers and heart failure. Cardiovasc Hematol Disord Drug Targets 2012; 12:51-55.
4. Barasch E, Gottdiener JS, Aurigemma G, Kitzman DW, Han J, Kop WJ, Tracy RP. Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study. Circ Heart Fail 2009; 2:303-310.
5. Doltra A, Stawowy P, Dietrich T, Schneeweis C, Fleck E, Kelle S. Magnetic resonance imaging of cardiovascular fibrosis and inflammation: from clinical practice to animal studies and back. BioMed Res Int 2013; 2013:676489.
6. Gupta S, Kumar S, Sopko N, Qin Y, Wei C, Kim IK. Thymosin beta4 and cardiac protection: implication in inflammation and fibrosis. Ann NY Acad Sci 2012; 1269:84-91.
7. Nicoletti A, Michel JB. Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc Res 1999; 41:532-543.
8. Kim CS, Kawada T, Kim BS, Han IS, Choe SY, Kurata T, Yu R. Capsaicin exhibits anti-inflammatory property by inhibiting IkB - a degradation in LPS-stimulated peritoneal macrophages. Cell Signal 2003; 15:299-306.
9. Matucci-Cerinic M, Marabini S, Jantsch S, Cagnoni M, Partsch G. Effects of capsaicin on the metabolism of rheumatoid arthritis synoviocytes in vitro. Ann Rheum Dis 1990; 49:598-602.
10. Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Obesity 2010; 18:780-787.
11. Hollis M, Wang DH. Transient receptor potential vanilloid in blood pressure regulation. Curr Opin Nephrol Hypertens 2013; 22:170-176.
12. White JP, Urban L, Nagy I. TRPV1 function in health and disease. Curr Pharm Biotechnol 2011; 12:130-144.
13. Torres-Narvaez JC, Mondragon Ldel V, Varela Lopez E, Perez-Torres I, Diaz Juarez JA, Suarez J, Hernandez GP. Role of the transient receptor potential vanilloid type 1 receptor and stretch-activated ion channels in nitric oxide release from endothelial cells of the aorta and heart in rats. Exp Clin Cardiol 2012; 17:89-94.
14. Thilo F, Liu Y, Schulz N, Gergs U, Neumann J, Loddenkemper C, Gollasch M, Tepel M. Increased transient receptor potential vanilloid type 1 (TRPV1) channel expression in hypertrophic heart. Biochem Biophys Res Comm 2010; 401:98-103.
15. Kai H, Mori T, Tokuda K, Takayama N, Tahara N, Takemiya K, Kudo H, Sugi Y, Fukui D, Yasukawa H, Kuwahara F, Imaizumi T. Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II. Hypertens Res 2006; 29:711-718.
16. Yang D, Ma S, Tan Y, Li D, Tang B, Chen J, Su X, Li G, Zhang X, Yang Y. Adrenergic receptor blockade-induced regression of pressure-overload cardiac hypertrophy is associated with inhibition of the calcineurin/ NFAT3/GATA4 pathway. Mol Med Res 2010; 3:497-501.
17. Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J, He H, Zhao Z, Cao T, Yan Z, Liu D, Arendshorst WJ, Huang Y, Tepel M, Zhu Z. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab 2010; 12:130-141.
18. Zhou H, Bian ZY, Zong J, Deng W, Yan L, Shen DF, Guo H, Dai J, Yuan Y, Zhang R, Lin YF, Hu X, Li H, Tang QZ. Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload. Hypertension 2012; 60:802-809.
19. Ma S, Yang D, Wang K, Tang B, Li D, Yang Y. Cryptotanshinone attenuates isoprenaline-induced cardiac fibrosis in mice associated with upregulation and activation of matrix metalloproteinase-2. Mol Med Rep 2012; 6:145-150.
20. Pchejetski D, Foussal C, Alfarano C, Lairez O, Calise D, Guilbeau-Frugier C, Schaak S, Seguelas MH, Wanecq E, Valet P, Parini A, Kunduzova O. Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1. Eur Heart J 2012; 33:2360-2369.
21. Yamamoto K, Ohishi M, Katsuya T, Ito N, Ikushima M, Kaibe M, Tatara Y, Shiota A, Sugano S, Takeda S, Rakugi H, Ogihara T. eletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension 2006; 47:718-726.
22. Guo T, Wang W, Zhang H, Liu Y, Chen P, Ma K, Zhou C. ISL1 promotes pancreatic islet cell proliferation. PloS One 2011; 6:e22387.
23. Ma S, Yang D, Li D, Tang B, Sun M, Yang Y. Cardiac extracellular matrix tenascin-C deposition during fibronectin degradation. Biochem Biophys Res Comm 2011; 409:321-327.
24. Jiang S, Jin F, Li D, Zhang X, Yang Y, Yang D, Li K, Yang Y, Ma S. Intermittent hypobaric hypoxia promotes atherosclerotic plaque instability in ApoE-deficient mice. High Alt Med Biol 2013; 14:175-180.
25. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000; 288:306-313.
26. Buckley CL, Stokes AJ. Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy. Channels 2011; 5:367-374.
27. Creemers EE, Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 2011; 89:265-272.
28. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117:568-575.
29. Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 2010; 225:631-637.
30. Teekakirikul P, Eminaga S, Toka O, Alcalai R, Wang L, Wakimoto H, Nayor M, Konno T, Gorham JM, Wolf CM, Kim JB, Schmitt JP, Molkentin JD, Norris RA, Tager AM, Hoffman SR, Markwald RR, Seidman CE, Seidman JG. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta. J Clin Invest 2010; 120:3520-3529.